301130 西点药业
已收盘 05-29 15:00:00
资讯
新帖
简况
西点药业（301130）披露2025年度分红派息实施公告，5月25日股价下跌4.07%
证券之星 · 05-25
西点药业（301130）披露2025年度分红派息实施公告，5月25日股价下跌4.07%
西点药业（301130）披露2025年年度股东会决议公告，5月22日股价上涨2.23%
证券之星 · 05-22
西点药业（301130）披露2025年年度股东会决议公告，5月22日股价上涨2.23%
西点药业(301130.SZ)子公司维生素B6注射液获得药品注册证书
智通财经 · 05-20
西点药业(301130.SZ)子公司维生素B6注射液获得药品注册证书
股市必读：西点药业（301130）5月19日披露最新机构调研信息
证券之星 · 05-20
股市必读：西点药业（301130）5月19日披露最新机构调研信息
股市必读：5月15日西点药业现1笔折价18.28%的大宗交易 合计成交224.37万元
证券之星 · 05-18
股市必读：5月15日西点药业现1笔折价18.28%的大宗交易 合计成交224.37万元
西点药业（301130）披露将参加2026年吉林辖区上市公司投资者网上集体接待日活动，5月15日股价下跌2.08%
证券之星 · 05-15
西点药业（301130）披露将参加2026年吉林辖区上市公司投资者网上集体接待日活动，5月15日股价下跌2.08%
股市必读：5月14日西点药业现1笔折价19.17%的大宗交易 合计成交224.03万元
证券之星 · 05-15
股市必读：5月14日西点药业现1笔折价19.17%的大宗交易 合计成交224.03万元
股市必读：5月13日西点药业现1笔折价19.13%的大宗交易 合计成交231.7万元
证券之星 · 05-14
股市必读：5月13日西点药业现1笔折价19.13%的大宗交易 合计成交231.7万元
5月11日西点药业发布公告，股东减持40.1万股
证券之星 · 05-11
5月11日西点药业发布公告，股东减持40.1万股
股市必读：5月8日西点药业现1笔折价21.92%的大宗交易 合计成交276.21万元
证券之星 · 05-11
股市必读：5月8日西点药业现1笔折价21.92%的大宗交易 合计成交276.21万元
每周股票复盘：西点药业（301130）股东户数增9.96%，一季报净利升10.74%
证券之星 · 05-03
每周股票复盘：西点药业（301130）股东户数增9.96%，一季报净利升10.74%
西点药业（301130）披露2025年度利润分配方案，4月29日股价上涨2.8%
证券之星 · 04-29
西点药业（301130）披露2025年度利润分配方案，4月29日股价上涨2.8%
图解西点药业年报：第四季度单季净利润同比下降281.33%
证券之星 · 04-29
图解西点药业年报：第四季度单季净利润同比下降281.33%
西点药业最新公告：草酸艾司西酞普兰片中选国家集采接续采购
证券之星 · 04-20
西点药业最新公告：草酸艾司西酞普兰片中选国家集采接续采购
西点药业（301130）披露2026年限制性股票激励计划激励对象名单核查结果，4月3日股价下跌3.88%
证券之星 · 04-03
西点药业（301130）披露2026年限制性股票激励计划激励对象名单核查结果，4月3日股价下跌3.88%
西点药业(301130.SZ)：蛋白琥珀酸铁获得化学原料药上市申请批准通知书
智通财经 · 03-26
西点药业(301130.SZ)：蛋白琥珀酸铁获得化学原料药上市申请批准通知书
西点药业(301130.SZ)：蛋白琥珀酸铁口服溶液获得药品注册证书
智通财经 · 03-23
西点药业(301130.SZ)：蛋白琥珀酸铁口服溶液获得药品注册证书
西点药业（301130）披露2026年限制性股票激励计划（草案），3月20日股价下跌4.42%
证券之星 · 03-20
西点药业（301130）披露2026年限制性股票激励计划（草案），3月20日股价下跌4.42%
西点药业（301130）披露回购股份结果暨股份变动公告，3月17日股价下跌2.39%
证券之星 · 03-17
西点药业（301130）披露回购股份结果暨股份变动公告，3月17日股价下跌2.39%
西点药业（301130）披露回购股份比例达到1%的进展公告，3月5日股价上涨0.49%
证券之星 · 03-05
西点药业（301130）披露回购股份比例达到1%的进展公告，3月5日股价上涨0.49%
加载更多
公司概况
公司名称：
吉林省西点药业科技发展股份有限公司
所属行业：
医药制造业
上市日期：
2022-02-23
主营业务：
吉林省西点药业科技发展股份有限公司的主营业务是化学原料药及制剂的研发、生产和销售。公司的主要产品是复方硫酸亚铁叶酸片、利培酮口崩片、草酸艾司西酞普兰片、瑞香素胶囊、富马酸亚铁、硫酸亚铁、瑞香素。
发行价格：
22.55
{"stockData":{"symbol":"301130","market":"SZ","secType":"STK","nameCN":"西点药业","latestPrice":28.3,"timestamp":1780038186000,"preClose":28.74,"halted":0,"volume":1400325,"delay":0,"changeRate":-0.0153,"floatShares":59017400,"shares":76494700,"eps":0.298,"marketStatus":"已收盘","change":-0.44,"latestTime":"05-29 15:00:00","open":28.92,"high":29.3,"low":27.83,"amount":39728900,"amplitude":0.0511,"askPrice":28.3,"askSize":8,"bidPrice":28.22,"bidSize":28,"shortable":0,"etf":0,"ttmEps":0.298,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780277400000},"marketStatusCode":5,"adr":0,"adjPreClose":28.74,"symbolType":"stock","openAndCloseTimeList":[[1780018200000,1780025400000],[1780030800000,1780038000000]],"highLimit":31.61,"lowLimit":25.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":76494685,"isCdr":false,"pbRate":2.49,"roa":"--","peRate":94.966443,"roe":"1.01%","epsLYR":0.2863,"committee":0.516667,"marketValue":2165000000,"turnoverRate":0.0237,"status":1,"floatMarketCap":1670000000},"requestUrl":"/m/hq/s/301130","defaultTab":"news","newsList":[{"id":"2638961556","title":"西点药业（301130）披露2025年度分红派息实施公告，5月25日股价下跌4.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638961556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638961556?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:59","pubTimestamp":1779721151,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，西点药业报收于29.96元，较前一交易日下跌4.07%，最新总市值为22.92亿元。该股当日开盘31.23元，最高31.76元，最低29.71元，成交额达4532.17万元，换手率为2.53%。近日，西点药业发布《2025年度分红派息实施公告》。股权登记日为2026年5月29日，除权除息日为2026年6月1日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500034394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637313893","title":"西点药业（301130）披露2025年年度股东会决议公告，5月22日股价上涨2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637313893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637313893?lang=zh_cn&edition=full","pubTime":"2026-05-22 18:00","pubTimestamp":1779444053,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，西点药业报收于31.23元，较前一交易日上涨2.23%，最新总市值为23.89亿元。该股当日开盘30.75元，最高31.49元，最低30.27元，成交额达4050.88万元，换手率为2.22%。公司于近日披露《2025年年度股东会决议公告》。公告显示，吉林省西点药业科技发展股份有限公司于2026年5月21日召开2025年年度股东会，会议由董事会召集，董事长张俊主持，采用现场与网络投票相结合方式召开。出席会议股东共32人，代表股份24,466,288股，占公司有表决权股份总数的31.9843%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200035841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636897889","title":"西点药业(301130.SZ)子公司维生素B6注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2636897889","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636897889?lang=zh_cn&edition=full","pubTime":"2026-05-20 11:50","pubTimestamp":1779249025,"startTime":"0","endTime":"0","summary":"智通财经APP讯，西点药业(301130.SZ)发布公告，公司控股子公司吉林省双胜丰药业有限责任公司于近日收到国家药品监督管理局签发的维生素B6注射液《药品注册证书》。维生素B6注射液适用于维生素B6缺乏的预防和治疗;防治异烟肼中毒。也可用于妊娠、放射病及抗癌药所致的呕吐，脂溢性皮炎等;全胃肠道外营养及因摄入不足所致营养不良、进行性体重下降时维生素B6的补充;新生儿遗传性维生素B6依赖综合征。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"西点药业(301130.SZ)子公司维生素B6注射液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301130","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636869500","title":"股市必读：西点药业（301130）5月19日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636869500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636869500?lang=zh_cn&edition=full","pubTime":"2026-05-20 03:08","pubTimestamp":1779217694,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，西点药业报收于32.17元，上涨1.93%，换手率2.33%，成交量1.38万手，成交额4397.8万元。当日关注点来自交易信息汇总：5月19日主力资金净流入316.49万元，呈现主力积极介入态势。来自机构调研要点：公司2025年研发费用达1125.31万元，占营收比重升至4.79%，主要用于瑞香素新适应症等研究。2025年业绩下降主要由于第四季度销售改革导致益源生销量阶段性下滑，叠加外购新产品形成的长期资产带来折旧摊销费用增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000003298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636016337","title":"股市必读：5月15日西点药业现1笔折价18.28%的大宗交易 合计成交224.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636016337","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636016337?lang=zh_cn&edition=full","pubTime":"2026-05-18 03:41","pubTimestamp":1779046871,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，西点药业报收于31.56元，下跌2.08%，换手率2.76%，成交量1.63万手，成交额5175.99万元。来自交易信息汇总：当日发生一笔折价18.28%的大宗交易，合计成交224.37万元，折价幅度显著。大宗交易5月15日西点药业现1笔折价18.28%的大宗交易，合计成交224.37万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635759033","title":"西点药业（301130）披露将参加2026年吉林辖区上市公司投资者网上集体接待日活动，5月15日股价下跌2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635759033","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635759033?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:39","pubTimestamp":1778855958,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，西点药业报收于31.56元，较前一交易日下跌2.08%，最新总市值为24.14亿元。该股当日开盘32.21元，最高32.26元，最低31.23元，成交额达5175.99万元，换手率为2.76%。西点药业于近日披露《关于参加2026年吉林辖区上市公司投资者网上集体接待日活动的公告》。公告显示，公司将于2026年5月19日15:00-16:30通过网络远程方式参加由吉林省证券业协会、深圳市全景网络有限公司共同举办的“2026年吉林辖区上市公司投资者网上集体接待日活动”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635935726","title":"股市必读：5月14日西点药业现1笔折价19.17%的大宗交易 合计成交224.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635935726","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635935726?lang=zh_cn&edition=full","pubTime":"2026-05-15 04:35","pubTimestamp":1778790911,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，西点药业报收于32.23元，下跌1.01%，换手率2.13%，成交量1.26万手，成交额4074.01万元。交易信息汇总资金流向5月14日主力资金净流出32.85万元；游资资金净流出129.4万元；散户资金净流入162.25万元。大宗交易5月14日西点药业现1笔折价19.17%的大宗交易，合计成交224.03万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500005545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635753733","title":"股市必读：5月13日西点药业现1笔折价19.13%的大宗交易 合计成交231.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635753733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635753733?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:23","pubTimestamp":1778703792,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，西点药业报收于32.56元，下跌1.06%，换手率2.62%，成交量1.54万手，成交额5070.26万元。当日关注点来自交易信息汇总：5月13日主力资金净流入93.82万元，游资资金同步净流入，合计超290万元资金呈净流入态势。大宗交易5月13日西点药业现1笔折价19.13%的大宗交易，合计成交231.7万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400004664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634407527","title":"5月11日西点药业发布公告，股东减持40.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634407527","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634407527?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:02","pubTimestamp":1778493720,"startTime":"0","endTime":"0","summary":"证券之星消息，5月11日西点药业发布公告《西点药业:关于持股5%以上股东及其一致行动人减持股份触及1%整数倍的公告》，其股东珠海横琴润汇易投资合伙企业(有限合伙)于2026年4月17日至2026年5月11日间合计减持40.1万股，占公司目前总股本的0.5242%，变动期间该股股价上涨4.73%，截止5月8日收盘报32.99元。股东增减持详情见下表：根据西点药业2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100025459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634742610","title":"股市必读：5月8日西点药业现1笔折价21.92%的大宗交易 合计成交276.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634742610","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634742610?lang=zh_cn&edition=full","pubTime":"2026-05-11 03:14","pubTimestamp":1778440452,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，西点药业报收于32.99元，上涨2.49%，换手率3.47%，成交量2.05万手，成交额6741.58万元。当日关注点来自交易信息汇总：5月8日主力资金净流出384.26万元，市场呈现主力与游资共同离场态势。大宗交易5月8日西点药业现1笔折价21.92%的大宗交易，合计成交276.21万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632677093","title":"每周股票复盘：西点药业（301130）股东户数增9.96%，一季报净利升10.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632677093","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632677093?lang=zh_cn&edition=full","pubTime":"2026-05-03 06:23","pubTimestamp":1777760592,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，西点药业报收于32.12元，较上周的30.06元上涨6.85%。本周，西点药业4月30日盘中最高价报32.43元。西点药业当前最新总市值24.57亿元，在化学制药板块市值排名146/150，在两市A股市值排名4994/5200。业绩披露要点：2026年一季度归母净利润918.48万元，同比上升10.74%。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为7849.0户，较2025年12月31日增加711.0户，增幅9.96%。现金分红总额预计为10,946,729.33元，占归属于母公司所有者净利润的49.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631252515","title":"西点药业（301130）披露2025年度利润分配方案，4月29日股价上涨2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631252515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631252515?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:48","pubTimestamp":1777463304,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，西点药业报收于31.62元，较前一交易日上涨2.8%，最新总市值为24.19亿元。该股当日开盘30.51元，最高31.78元，最低30.49元，成交额达5099.77万元，换手率为2.75%。公司于2026年4月29日披露《2025年度利润分配方案的公告》。公告显示，吉林省西点药业科技发展股份有限公司2025年度利润分配方案为：向全体股东每10股派发现金股利1.45元（含税），不转增股本，不送红股。现金分红总额预计为10,946,729.33元，占归属于母公司所有者净利润的49.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631582507","title":"图解西点药业年报：第四季度单季净利润同比下降281.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631582507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631582507?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:14","pubTimestamp":1777396454,"startTime":"0","endTime":"0","summary":"证券之星消息，西点药业2025年年报显示，当年度公司主营收入2.35亿元，同比下降8.41%；归母净利润2190.0万元，同比下降45.62%；扣非净利润1753.7万元，同比下降49.53%；其中2025年第四季度，公司单季度主营收入4589.5万元，同比下降28.09%；单季度归母净利润-1124.63万元，同比下降281.33%；单季度扣非净利润-1227.16万元，同比下降309.39%；负债率11.94%，投资收益299.63万元，财务费用1.85万元，毛利率76.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900003510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628319743","title":"西点药业最新公告：草酸艾司西酞普兰片中选国家集采接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2628319743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628319743?lang=zh_cn&edition=full","pubTime":"2026-04-20 16:23","pubTimestamp":1776673432,"startTime":"0","endTime":"0","summary":"西点药业公告称，公司参与国家组织集采药品协议期满品种接续采购，产品草酸艾司西酞普兰片获得中选资格。中选价格分别为5.92元/盒和22.51元/盒，首年约定采购量为346.62万片，供应除河北省外的全国其他省区，采购周期至2028年12月31日。该产品2024年销售收入为1011.06万元，占主营业务收入的3.96%。本次中选有利于扩大产品销量，提高市场占有率，对公司未来经营发展具有积极影响。但后续事项及对业绩影响尚存在不确定性，敬请投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000021536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624307663","title":"西点药业（301130）披露2026年限制性股票激励计划激励对象名单核查结果，4月3日股价下跌3.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624307663","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624307663?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:27","pubTimestamp":1775226435,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，西点药业报收于31.22元，较前一交易日下跌3.88%，最新总市值为23.88亿元。该股当日开盘32.16元，最高32.48元，最低31.02元，成交额达8347.1万元，换手率为4.48%。公告显示，公司董事会薪酬与考核委员会对2026年限制性股票激励计划拟首次授予激励对象名单的公示情况进行核查。公示时间为2026年3月21日至3月31日，通过公司内部张贴及OA系统公示，未收到任何异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300043620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622803968","title":"西点药业(301130.SZ)：蛋白琥珀酸铁获得化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2622803968","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622803968?lang=zh_cn&edition=full","pubTime":"2026-03-26 11:48","pubTimestamp":1774496904,"startTime":"0","endTime":"0","summary":"智通财经APP讯，西点药业(301130.SZ)发布公告，公司于近日收到国家药品监督管理局签发的蛋白琥珀酸铁《化学原料药上市申请批准通知书》。蛋白琥珀酸铁为铁剂，用于由于铁的摄入量不足或吸收障碍、急性或慢性失血以及感染所引起的隐性或显性缺铁性贫血，妊娠及哺乳期贫血等绝对和相对缺铁性贫血。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"西点药业(301130.SZ)：蛋白琥珀酸铁获得化学原料药上市申请批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301130","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621738667","title":"西点药业(301130.SZ)：蛋白琥珀酸铁口服溶液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2621738667","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621738667?lang=zh_cn&edition=full","pubTime":"2026-03-23 15:50","pubTimestamp":1774252224,"startTime":"0","endTime":"0","summary":"智通财经APP讯，西点药业(301130.SZ)发布公告，公司于近日收到国家药品监督管理局(以下简称“国家药监局”)签发的蛋白琥珀酸铁口服溶液《药品注册证书》。蛋白琥珀酸铁口服溶液，用于由于铁的摄入量不足或吸收障碍、急性或慢性失血以及感染所引起的隐性或显性缺铁性贫血，妊娠及哺乳期贫血等绝对和相对缺铁性贫血。该产品的获批进一步丰富了公司的产品线，有助于提升公司产品的市场竞争力。由于医药产品具有高科技、高风险、高附加值的特点，药品获得批件后，产品销售易受到行业政策变动、招标采购、市场环境变化等因素影响，存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"西点药业(301130.SZ)：蛋白琥珀酸铁口服溶液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620177732","title":"西点药业（301130）披露2026年限制性股票激励计划（草案），3月20日股价下跌4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620177732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620177732?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:34","pubTimestamp":1774017263,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，西点药业报收于29.42元，较前一交易日下跌4.42%，最新总市值为22.5亿元。该股当日开盘30.83元，最高31.15元，最低29.36元，成交额达5933.54万元，换手率为3.35%。近日，西点药业披露《2026年限制性股票激励计划（草案）》，拟向不超过20名核心业务人员授予100万股第二类限制性股票，股票来源为二级市场回购，授予价格为15.42元/股。本激励计划有效期最长不超过36个月，分两个归属期，归属比例各为50%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000043820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620147576","title":"西点药业（301130）披露回购股份结果暨股份变动公告，3月17日股价下跌2.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620147576","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620147576?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:56","pubTimestamp":1773759374,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，西点药业报收于31.02元，较前一交易日下跌2.39%，最新总市值为23.73亿元。该股当日开盘31.93元，最高31.99元，最低30.9元，成交额达3024.95万元，换手率为1.63%。公司于2026年3月17日披露《关于回购股份结果暨股份变动的公告》。回购期间相关主体无买卖公司股票行为。回购完成后公司股权分布仍符合上市条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617510637","title":"西点药业（301130）披露回购股份比例达到1%的进展公告，3月5日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617510637","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617510637?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:29","pubTimestamp":1772702953,"startTime":"0","endTime":"0","summary":"截至2026年3月5日收盘，西点药业报收于30.77元，较前一交易日上涨0.49%，最新总市值为23.54亿元。该股当日开盘31.08元，最高31.24元，最低30.7元，成交额达2479.22万元，换手率为1.36%。公司于近日披露《关于回购股份比例达到1%的进展公告》。截至2026年3月5日，公司已累计回购股份765,000股，占公司总股本的1.0001%，最高成交价为31.42元/股，最低成交价为30.20元/股，成交总金额为23,508,482元。上述回购符合相关法规及公司回购方案的规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500028321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780164353517,"stockEarnings":[{"period":"1week","weight":-0.0891},{"period":"1month","weight":-0.1003},{"period":"3month","weight":-0.1046},{"period":"6month","weight":-0.0725},{"period":"1year","weight":-0.0081},{"period":"ytd","weight":-0.0032}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0227},{"period":"6month","weight":0.0463},{"period":"1year","weight":0.2096},{"period":"ytd","weight":0.0251}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"吉林省西点药业科技发展股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7849人(较上一季度增加9.96%)","perCapita":"7519股","listingDate":"2022-02-23","address":"吉林省吉林市磐石市磐石经济开发区西点大街777号","registeredCapital":"7649万元","survey":" 吉林省西点药业科技发展股份有限公司的主营业务是化学原料药及制剂的研发、生产和销售。公司的主要产品是复方硫酸亚铁叶酸片、利培酮口崩片、草酸艾司西酞普兰片、瑞香素胶囊、富马酸亚铁、硫酸亚铁、瑞香素。","listedPrice":22.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西点药业(301130)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西点药业(301130)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西点药业,301130,西点药业股票,西点药业股票老虎,西点药业股票老虎国际,西点药业行情,西点药业股票行情,西点药业股价,西点药业股市,西点药业股票价格,西点药业股票交易,西点药业股票购买,西点药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西点药业(301130)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西点药业(301130)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}